435 related articles for article (PubMed ID: 33987095)
1. Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.
Sauer S; Reed DR; Ihnat M; Hurst RE; Warshawsky D; Barkan D
Front Oncol; 2021; 11():659963. PubMed ID: 33987095
[TBL] [Abstract][Full Text] [Related]
2. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
Hen O; Barkan D
Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
[TBL] [Abstract][Full Text] [Related]
3. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
4. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Dormant Cancer Cells and Their Microenvironment.
Linde N; Fluegen G; Aguirre-Ghiso JA
Adv Cancer Res; 2016; 132():45-71. PubMed ID: 27613129
[TBL] [Abstract][Full Text] [Related]
6. Transdifferentiation of type II alveolar epithelial cells induces reactivation of dormant tumor cells by enhancing TGF-β1/SNAI2 signaling.
Zhou Y; Liu Q; Dai X; Yan Y; Yang Y; Li H; Zhou X; Gao W; Li X; Xi Z
Oncol Rep; 2018 Apr; 39(4):1874-1882. PubMed ID: 29436661
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
8. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy.
Vera-Ramirez L
Semin Cancer Biol; 2020 Feb; 60():28-40. PubMed ID: 31400500
[TBL] [Abstract][Full Text] [Related]
9. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
Front Oncol; 2018; 8():72. PubMed ID: 29616190
[TBL] [Abstract][Full Text] [Related]
10. Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patients.
Ausch C; Buxhofer-Ausch V; Olszewski U; Hamilton G
Exp Ther Med; 2010 Jan; 1(1):9-12. PubMed ID: 23136585
[TBL] [Abstract][Full Text] [Related]
11. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.
Shor RE; Dai J; Lee SY; Pisarsky L; Matei I; Lucotti S; Lyden D; Bissell MJ; Ghajar CM
Mol Oncol; 2022 Jan; 16(1):130-147. PubMed ID: 34058066
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer.
Ring A; Spataro M; Wicki A; Aceto N
Front Cell Dev Biol; 2022; 10():929893. PubMed ID: 35837334
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients treated in a single neurosurgical reference centre for brain metastasis caused by dormant disseminated cells.
Ferlini L; Peluso L; Lolli V; Gaspard N; Lefranc F
Oncol Lett; 2021 Jun; 21(6):454. PubMed ID: 33907564
[TBL] [Abstract][Full Text] [Related]
16. Remodeling the ECM: Implications for Metastasis and Tumor Dormancy.
Di Martino JS; Akhter T; Bravo-Cordero JJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638400
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Metastatic Tumor Dormancy.
Osisami M; Keller ET
J Clin Med; 2013 Sep; 2(3):136-50. PubMed ID: 26237067
[TBL] [Abstract][Full Text] [Related]
18. The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.
Risson E; Nobre AR; Maguer-Satta V; Aguirre-Ghiso JA
Nat Cancer; 2020 Jul; 1(7):672-680. PubMed ID: 33681821
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.
Pantel K; Alix-Panabières C
Bonekey Rep; 2014; 3():584. PubMed ID: 25419458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
